Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
36 vs 48 Weeks PegIntron + Ribavirin in HCV Genotype 1 Non-RVR Responders
NCT01683786Phase 4Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Aug 2011
- Primary completion
- Dec 2014
- Modality
- Polymer-based Nanoparticles, Orthosteric Ligands, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2b, ribavirin in hepatitis C (HCV), sponsored by Chang Gung Memorial Hospital. Status: unknown.
02
Drugs
peginterferon alfa-2bribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01683786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01683786.